Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
Agency: Food and Drug Administration
Assistance Listings: 93.103 -- Food and Drug Administration Research
Description
The purpose of this Notice of Funding Opportunity (NOFO) is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare diseases or conditions. Additionally, through the funding of collaborative, efficient, and/or innovative clinical trials, FDA expects to increase the number of approved treatments for rare diseases and exert a broad and positive impact on rare disease drug development.
Eligibility
Eligible applicants
Miscellaneous
- Other
Additional information
Grantor contact information
Description
Email: Patrick.Johnson@fda.hhs.gov
Documents
| File name | Description | Last updated |
|---|---|---|
| Foa_Content_of_RFA-FD-25-020.pdf | Notice of Funding Opportunity - Revised | Apr 13, 2026 02:12 PM UTC |
Link to additional information
--
Closing: May 16, 2028
Award
$--
Program Funding
--
Expected awards
$--
Award Minimum
$900,000
Award Maximum
Funding opportunity number:
RFA-FD-25-020
Cost sharing or matching requirement:
Funding instrument type:
Grant
Opportunity Category:
Discretionary
Opportunity Category Explanation:
Category of Funding Activity:
Agriculture
Consumer protection
Food and nutrition
Category Explanation:
History
Version:
3
Posted date:
July 11, 2025
Archive date:
June 15, 2028
